AI-generated summary
The authors describe one 48-year-old woman with reticular erythematous mucinosis who applied pimecrolimus 1 percent cream twice daily and had pulsed dye laser on the opposite side of her chest and back. After five months of pimecrolimus, the lesions completely resolved, with results the authors describe as comparable to the laser-treated side. The authors conclude both treatments appear effective and safe, but the report covers a single patient.
- Participants
- 1
- Who or what was studied
- One 48-year-old woman with reticular erythematous mucinosis (REM) syndrome who had previously received hydroxychloroquine with only a fair response.
- Limits stated in the abstract
- The report describes a single patient, so the findings cannot be generalized and no control group or comparison beyond the patient's two body sides is described.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.